Research progress of lymph node metastasis in esophageal cancer

Abstract

YING Yin-Yin, XU Ya-Ping, MAO Wei-Min. Research progress of lymph node metastasis in esophageal cancer[J]. Journal of International Oncology, 2014, 41(12): 921-925.

［1］王永岗, 汪良骏, 张德超, 等. 胸段食管鳞癌淋巴结转移特点及临床意义［J］. 中华肿瘤杂志, 2000, 22(3): 241243. ［2］ Kim DU, Lee JH, Min BH, et al. Risk factors of lymph node metastasis in T1 esophageal squamous cell carcinoma［J］. J Gastroenterol Hepatol, 2008, 23(4): 619625. ［3］陈跃军, 邹求益, 朱广, 等. 胸段食管癌淋巴结转移特点的临床研究［J］. 中华胃肠外科杂志, 2013, 16(9): 835837. ［4］ Gaur P, Sepesi B, Hofstetter WL, et al. Endoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer［J］. Cancer, 2011, 117(1): 6369. ［5］ Wu N, Pang LW, Chen ZM, et al. Tumour length is an independent prognostic factor of esophageal squamous cell carcinomas［J］. Chin Med J (Engl), 2012, 125(24): 44454448. ［6］刘超,葛红,买玲, 等. 胸段食管鳞癌淋巴结转移规律及其影响因素分析［J］. 中华肿瘤防治杂志, 2013, 20(13):10251029. ［7］ Kaneshiro DK, Post JC, Rybicki L, et al. Clinical significance of the duplicated muscularis mucosae in Barrett esophagusrelated superficial adenocarcinoma［J］. Am J Surg Pathol, 2011, 35(5): 697700. ［8］ Raja S, Rice TW, Goldblum JR, et al. Esophageal submucosa: the watershed for esophageal cancer［J］. J Thorac Cardiovasc Surg, 2011, 142(6): 14031411. ［9］ Feng JF, Zhao Q, Chen QX. Prognostic value of subcarinal lymph node metastasis in patients with esophageal squamous cell carcinoma［J］. Asian Pac J Cancer Prev, 2013, 14(5): 31833186. ［10］ Kunisaki C, Makino H, Kimura J, et al. Impact of lymphnode metastasis site in patients with thoracic esophageal cancer［J］. J Surg Oncol, 2010, 101(1): 3642. ［11］ Akutsu Y, Shuto K, Kono T, et al. The number of pathologic lymph nodes involved is still a significant prognostic factor even after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma［J］. J Surg Oncol, 2012, 105(8): 756760. ［12］ Kelty CJ, Kennedy CW, Falk GL. Ratio of metastatic lymph nodes to total number of nodes resected is prognostic for survival in esophageal carcinoma［J］. J Thorac Oncol, 2010, 5(9): 14671471. ［13］冯键, 茅腾, 陈文虎, 等. 转移淋巴结的数量和范围对食管癌预后的影响［J］. 中华胃肠外科杂志, 2011, 14(9):715718. ［14］祝淑钗, 宋长亮, 沈文斌. 食管癌根治性切除术后患者预后的影响因素分析［J］. 中华肿瘤杂志, 2012, 34(4): 281286. ［15］孙志钢, 王洲, 刘相燕，等. pN0食管癌IvorLewis手术后淋巴结转移性复发的危险因素［J］. 中华胸心血管外科杂志, 2011, 27(2): 108111. ［16］ Koenig AM, Prenzel KL, Bogoevski D, et al. Strong impact of micrometastatic tumor cell load in patients with esophageal carcinoma［J］. Ann Surg Oncol, 2009, 16(2): 454462. ［17］ Sato F, Shimada Y, Li Z, et al. Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma［J］. Br J Surg, 2001, 88(3): 426432. ［18］ Prenzel KL, Hlscher AH, Drebber U, et al. Prognostic impact of nodal micrometastasis in early esophageal cancer［J］. Eur J Surg Oncol, 2012, 38(4): 314318. ［19］ Uenosono Y, Arigami T, Yanagita S, et al. Sentinel node navigation surgery is acceptable for clinical T1 and N0 esophageal cancer［J］. Ann Surg Oncol, 2011, 18(7): 20032009. ［20］ Thompson SK, Bartholomeusz D, Jamieson GG. Sentinel lymph node biopsy in esophageal cancer: should it be standard of care? ［J］. J Gastrointest Surg, 2011, 15(10): 17621768. ［21］ Groth SS, Virnig BA, Whitson BA, et al. Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: data from the Surveillance Epidemiology and End Results database［J］. J Thorac Cardiovasc Surg, 2010, 139(3): 612620. ［22］ Greenstein AJ, Litle VR, Swanson SJ, et al. Effect of the number of lymph nodes sampled on postoperative survival of lymph nodenegativeesophageal cancer［J］. Cancer, 2008, 112(6): 12391246. ［23］ Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer［J］. Ann Surg, 2010, 251(1): 4650. ［24］ Shridhar R, Hoffe SE, Almhanna K, et al. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy［J］. Ann Surg Oncol, 2013, 20(9): 30383043. ［25］ Zhu Z, Yu W, Li H, et al. Nodal skip metastasis is not a predictor of survival in thoracic esophageal squamous cell carcinoma［J］. Ann Surg Oncol, 2013, 20(9): 30523058. ［26］ Igaki H, Tachimori Y, Kato H. Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3field dissection［J］. Ann Surg, 2004, 239(4): 483490. ［27］ Fang WT, Chen WH, Chen Y, et al. Selective threefield lymphadenectomy for thoracic esophageal squamous carcinoma［J］. Dis Esophagus, 2007, 20(3): 206211. ［28］ Ma JB, Song YP, Yu JM, et al. Feasibility of involvedfield conformal radiotherapy for cervical and upperthoracic esophageal cancer［J］. Onkologie, 2011, 34(11): 599604.

[1]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337.
[2]	Liu Jing, Liu Qin, Huang Mei.Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm[J]. Journal of International Oncology, 2024, 51(5): 267-273.
[3]	Wan Fang, Yang Gang, Li Rui, Wan Qijing.Expression levels and clinical significance of serum miR-497 and miR-383 in patients with esophageal cancer[J]. Journal of International Oncology, 2024, 51(4): 204-209.
[4]	Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients[J]. Journal of International Oncology, 2024, 51(1): 37-42.
[5]	Shandong Medical Association Multidisciplinary Joint Committee on Lung Cancer.Shandong Provincial Medical Association multidisciplinary standardized diagnosis and treatment guidelines for esophageal carcinoma （2023 Edition）[J]. Journal of International Oncology, 2023, 50(7): 385-397.
[6]	Zeng Liwu, Du Yuqiang, Zhang Peng, Tao Kaixiong.Progress in imaging evaluation of lateral lymph node metastasis in rectal cancer[J]. Journal of International Oncology, 2023, 50(4): 248-251.
[7]	Ji Shiyu, Zhang Mingxin, Xie Huahong, Bai Yuan, Wang Tong.Observation on the efficacy of different stents in the treatment of patients with advanced esophageal cancer[J]. Journal of International Oncology, 2023, 50(2): 76-81.
[8]	Gong Heyi, Yi Yan, Zhang Jian, Li Baosheng.Management strategies for locally advanced operable esophageal carcinoma achieving clinical complete response after neoadjuvant chemoradiotherapy[J]. Journal of International Oncology, 2023, 50(12): 745-750.
[9]	Wu Puyuan, Qi Liang, Wang Tao, Shi Minke, Sun Yuwei, Wang Lifeng, Liu Baorui, Yan Jing, Ren Wei.Efficacy of postoperative radiotherapy based on modified clinical target volume according to high-frequency recurrence regions in patients with esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2022, 49(8): 464-472.
[10]	Xia Lingling, Chen Yongshun, Li Bin, Ning Tingting, Zhang Caiyutian.Comparison of safety and efficacy between chemoradiotherapy and chemotherapy after R0 resection in pN₊esophageal squamous cell carcinoma patients[J]. Journal of International Oncology, 2022, 49(6): 334-339.
[11]	Ye Qian, Ling Zhi, Liu Shenxiang, Lu Guotao, Yin Xudong.Effects of sarcopenia on the clinical efficacy and prognosis of radical radiotherapy in elderly patients with esophageal cancer[J]. Journal of International Oncology, 2022, 49(4): 199-205.
[12]	Zhou Jianfeng, Wang Tiejun.Targeted therapy and immunotherapy of esophageal cancer[J]. Journal of International Oncology, 2022, 49(4): 237-242.
[13]	Liu Jia, Ge Xiaolin, Di Xiaoke, Shi Yujing, Zeng Yuting.Efficacy analysis of Xiyanping injection on prevention of radioactive esophagitis[J]. Journal of International Oncology, 2022, 49(3): 146-150.
[14]	Zhang Junpeng, Yu Yanyan, Li Baosheng.Mechanism of lncRNA and circRNA regulating the sensitivity of radiotherapy and chemotherapy in esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2022, 49(3): 185-189.
[15]	Geng Hui, Hu Fengchao, Lu Hongchao, Guo Jungang, Qi Zengping.Effects of TPF regimen and IMRT on immune function and survival prognosis of patients with advanced esophageal cancer[J]. Journal of International Oncology, 2022, 49(2): 84-88.

Research progress of lymph node metastasis in esophageal cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments